how many americans are taking glp 1 drugs GLP-1 Survey: 75% of Users Report Reduced Spending on Food, Alcohol KFF Health Tracking Poll May

Because patient safety often depends on the details we don't overlook

This Alabama facility will produce Lillys new oral GLP-1 agent orforglipron

is funded by a Sir Jules Thorn Award for Biomedical Science

While their choices may help to inform the decision-making of plan sponsors in other industries, ultimately all employers will need to weigh the clinical and financial issues to ensure their benefit design reflects their philosophy, program objectives and fiscal reality.

Among the 4 brand-name products with paragraph IV submissions, the median time from brand-name approval to first paragraph IV challenge was 6.8 years (IQR: 6.0-7.4)

Certain conditions, like a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, can make these medications unsuitable